Biodegradable LNG Implant (SIPPR)

Description: Biodegradable PLGA implant releasing levonorgestrel (LNG) for 12 months or longer.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: 12 months or more

Regimen:
  • Single insertion

Dose: 22mg or more

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: PLGA/PLA

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Shanghai Institute of Planned Parenthood Research (SIPPR)

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Began discovery in: 2013

Active Development: Yes

Status Details:
  • This project is in early stage proof of concept (POC). Preliminary investigations of formulation and process have been done. The in vivo release experiments are ongoing and data has been achieved to prove the feasibility of this project.

Additional Information

Vertical Tabs

Print